Compare BLCO & AX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLCO | AX |
|---|---|---|
| Founded | 1853 | 1999 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 4.8B |
| IPO Year | 2022 | 2005 |
| Metric | BLCO | AX |
|---|---|---|
| Price | $17.44 | $91.10 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 7 |
| Target Price | $17.31 | ★ $97.07 |
| AVG Volume (30 Days) | 360.9K | ★ 378.5K |
| Earning Date | 02-18-2026 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.44 |
| Revenue | ★ $4,976,000,000.00 | $1,202,571,000.00 |
| Revenue This Year | $8.06 | $17.20 |
| Revenue Next Year | $5.79 | $9.57 |
| P/E Ratio | ★ N/A | $12.18 |
| Revenue Growth | 6.23 | ★ 6.69 |
| 52 Week Low | $10.45 | $54.46 |
| 52 Week High | $18.34 | $93.84 |
| Indicator | BLCO | AX |
|---|---|---|
| Relative Strength Index (RSI) | 62.34 | 67.26 |
| Support Level | $16.22 | $84.83 |
| Resistance Level | $17.26 | $89.21 |
| Average True Range (ATR) | 0.34 | 1.95 |
| MACD | -0.03 | 0.11 |
| Stochastic Oscillator | 91.73 | 93.08 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment. The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.